New Zealand Pharmaceuticals and Healthcare Report Q4 2013: Business Monitor International Market Research Reports

Business Monitor International Market Research Reports Market Reports Online XML Feed

Best Start-Up Jobs. 100s of jobs @ tech companies and start-ups in New York and San Francisco. Free for candidates. Get hired now! From our sponsors

New Zealand Pharmaceuticals and Healthcare Report Q4 2013 Aug 7th 2013, 00:00 Price: $ 1295   BMI View: Limited funding for New Zealand's Pharmaceutical Management Agency (PHARMAC) will continue to be a source of discontent for innovative drugmakers. The consequential reduction in market access is also a cause for concern among patient populations. We highlight that New Zealand's pharmaceutical market continues to rank behind Australia in terms of the attractiveness of its business environment. Headline Expenditure Forecasts ? Pharmaceuticals: NZD1.38bn (US$1.12bn) in 2012 to NZD1.42bn (US$1.06bn) in 2013; +2.9% in local currency and 1.6% in US dollar terms. ? Healthcare: NZD21.25bn (US$17.21bn) in 2012 to NZD22.08bn (US$17.67bn) in 2013; +3.9% in local currency and 2.6% in US dollar terms. ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/266779.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions